Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Forecast parameters
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data Sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Vaginitis therapeutics market 3600 synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Disease type trends
2.1.4 Drug class trends
2.1.5 Route of administration trends
2.1.6 Mode trends
2.1.7 Distribution channel trends
Chapter 3 Vaginitis Therapeutics Market Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 High prevalence of vaginal infections
3.2.1.2 Growing awareness about women's health and the availability of effective treatments
3.2.1.3 Advancements in drug developmentIncreasing cases of cancer
3.2.2 Industry pitfalls & challenges
3.2.2.1 Growing antibiotic resistance
3.3 Growth potential analysis
3.3.1 By disease type
3.3.2 By drug class
3.3.3 By route of administration
3.3.4 By mode
3.3.5 By distribution channel
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix, 2022
4.5 Strategic dashboard, 2022
Chapter 5 Vaginitis Therapeutics Market Size and Forecast, By Disease Type, 2018 - 2032 (USD Million)
5.1 Key trends, by disease type
5.2 Bacterial vaginosis
5.3 Candidiasis
5.4 Trichomoniasis
5.5 Other disease types
Chapter 6 Vaginitis Therapeutics Market Size and Forecast, By Drug Class, 2018 - 2032 (USD Million)
6.1 Key trends, by drug class
6.2 Anti-bacterial
6.3 Anti-fungal
6.4 Anti-protozoal
6.5 Other drug classes
Chapter 7 Vaginitis Therapeutics Market Size and Forecast, By Route of Administration, 2018 - 2032 (USD Million)
7.1 Key trends, by route of administration
7.2 Oral
7.3 Topical
Chapter 8 Vaginitis Therapeutics Market Size and Forecast, By Mode, 2018 - 2032 (USD Million)
8.1 Key trends, by mode
8.2 Over-the-counter
8.3 Prescription
Chapter 9 Vaginitis Therapeutics Market Size and Forecast, By Distribution Channel, 2018 - 2032 (USD Million)
9.1 Key trends, by distribution channel
9.2 Hospital pharmacy
9.3 Retail pharmacy
9.4 Online pharmacy
Chapter 10 Vaginitis Therapeutics Market Size and Forecast, By Region (USD Million)
10.1 Key trends, by region
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Rest of Latin America
10.6 Middle East & Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 Rest of Middle East & Africa
Chapter 11 Company Profiles
11.1 Pfizer, Inc.
11.2 Merck & Co.
11.3 Novartis AG
11.4 Bayer AG
11.5 Lupin Pharmaceuticals, Inc.
11.6 Sanofi SA
11.7 Dr. Reddy’s Laboratories Ltd
11.8 Sun Pharmaceuticals Pvt Ltd
11.9 Cipla Ltd
11.10 Takeda Pharmaceuticals
11.11 Astellas Pharma
